Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Invasive Cardiology|December 4, 2001
Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stentingD L Bhatt, S R Kapadia, C T Bajzer, et al.
Stroke|October 6, 2001
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapyS R Kapadia, C T Bajzer, K M Ziada, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.
International Journal of Laboratory Hematology|May 12, 2012
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery diseaseA A Timur, G Murugesan, L Zhang, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 18, 2011
Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial diseaseK G Smolderen, K Wang, G de Pouvourville, et al.
Diabetes, Obesity & Metabolism|August 19, 2014
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgeryS K Malin, J Bena, B Abood, et al.
European Journal of Preventive Cardiology|August 23, 2013
Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH RegistryG Ducrocq, D L Bhatt, J Labreuche, et al.
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
Heart Asia|June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registryS Goto, Y Ikeda, J C N Chan, et al.
Circulation|December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudyS P Marso, A M Lincoff, S G Ellis, et al.
Pageof 6